Bruker announced today that its Anthony Mattacchione will resign as chief financial officer and senior VP, effective Mar. 16, 2018. Mattacchione has accepted a position as CFO of Albany Molecular Research, commencing in Apr. 2018. VP and corporate controller Gerald N. Herman will serve as Bruker's princapl accounting officer, effective immediately. Herman joined the firm in 2016 as VP-corporate controller. Prior to that, he served as corporate VP-clinical operations of Parexel international from 2014 to Feb. 2016, and before that, corporate VP of Parexel from 2008 to 2013. Before that, Herman served as VP-corporate controller of Presstek.